Shared Savings model will have to mature and refine to adapt to industry changes
The number of accountable care organizations (ACOs) has doubled during the past year with Medicare ACOs taking the lead over commercial entries into the healthcare space, according to Leavitt Partners.
Since the inauguration of the Medicare Pioneer ACO and Shared Savings programs, the model has grown to 106 total ACO players providing care for about 1.6 million beneficiaries, according to the Medicare Payment Advisory Commission (MedPAC).
Despite the growth of Medicare ACOs, Stephen Thome, senior manager, healthcare practice for Ernst & Young in Cleveland, says commercial ACOs are growing at an organic pace and are not affected by the same regulations as their Medicare counterparts-federal governance, management and leadership requirements.
“Commercial payers have come up with accommodations to share start-up costs, and the process for attributing patients to the ACO can be more transparent and timely,” he says.
He also says ACOs will need to develop a more sustainable payment model to survive long term. The initial Shared Savings model will need to mature to provide more predictable payment streams and to align incentives for payers and providers.
“They also will need to deliver on medical management, and provide better care for less,” Thome says. “Otherwise, they will become irrelevant and add another layer of costs.”
But as the competition among ACOs increases, he believes that the healthcare marketplace will see a bend in the cost curve and improved quality of care.
“Five years ago, the partnerships between plans and providers in an ACO would have been unthinkable,” he says.
Any ACO partnership would require an information technology infrastructure, says Gene Muise, director of pharmacy for Mount Auburn Cambridge Independent Practice Assn. (MACIPA), a 500-multispecialty physician group in Cambridge, Mass., and an original Pioneer ACO.
“If ACOs can meet performance measures, improve quality, save money and boost buy-in and communications with health plans, the model holds promise for the future,” Muise says.
MACIPA has experience with models similar to an ACO as far back as 1985, when it secured risk-based contracts covering individuals in HMOs offered by Tufts Health Plan, followed by Blue Cross Blue Shield of Massachusetts and Harvard Pilgrim Health Care in the mid-1990s.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More